3 Pharma Trends for 2024: All about market access
Pharma is facing a new set of launch, market access and strategic challenges as the pandemic has changed some market characteristics for good.
Our products
Pharma is facing a new set of launch, market access and strategic challenges as the pandemic has changed some market characteristics for good.
The coronavirus is forcing pharma to think creatively about remote working in a constrained environment. Digital technology will be crucial in softening the pandemic’s multiple impacts on drug launches.
The pharmaceutical market in 2020 is more about product diversity, breakthrough science and new therapeutic targets than spectacular launch volumes.
The pharmaceutical market in 2020 is more about product diversity, breakthrough science and new therapeutic targets than spectacular launch volumes.
We take a look at the Top 6 Pharma Trends for 2019: From slowing sales growth, biosimilars getting serious, growing pressure on US pricing, more Brexit uncertainty, value focused R&D to the need to address the industry’s ‘me-too’ deficit.
The right tender management tools will help pharmaceutical and biotechnology companies overcome the market access challenges of a growing but complex tenders sector.
The right digital management tools will help pharmaceutical companies overcome the market access challenges of a growing but complex tenders sector.
Effective and proactive tender management is critical to capitalising on new growth opportunities for pharmaceuticals and vaccines worldwide.
TRiBECA Knowledge needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Notice.